SUPERBIOTICS
ActiveThe computed 12-month bankruptcy probability of SUPERBIOTICS is 3.9% (moderate). The 2025 annual accounts show negative equity (€-10k) and a net result of €-94k. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 18% of 50 sector peers (fiscal year 2025). The company has been active since 2019 and the Belgian State Gazette contains no insolvency or warning signals.
Checked score
Score 2025
7
/ 100
Critical▼ -48 vs 2024
The score combines four axes. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability100▲+100
Solvency34▼-66
Growth55▼-13
Stability100
Bankruptcy probability, 12 months
3.9%
Moderate
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.54 against 3.15 in 2024), and equity is negative.
Credit advice for your own amount and term
Signals
Nine signals. The signal on the left, the evidence on the right.
+raises risk○neutral
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Higher-failure-rate sector
In this sector companies fail more often than the Belgian average.
Gazette · bankruptcies per sector, NACE 10
Relative position
BE, all sectors
reference
Sector 10
higher
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-5.3%
Return on assets
-50.9%
Age of the figures
8 mo
raises risk · Negative equity
Equity is negative for financial year 2025: liabilities exceed assets. This is the trigger point of the alarm-bell procedure (Belgian CAC).
NBB · annual accounts 2025Equity per financial year
19202122232425
2019 to 2025 · latest year -€10k
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 7 filingsDeviation from the deadline
2025
31 d late
2024
14 d late
2023
22 d late
2022
29 d late
2021
30 d late
2020
30 d late
2019
41 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
12-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Turnover
€73k▲ 523%
2022 · €12k
2019: €20k
2020: €52k
2021: €8k
2022: €12k
2019 → 2023
EBIT margin
59.0%▲ 90.2pp
2022 · -31.2%
2019: -15.0%
2020: 33.1%
2021: -729.9%
2022: -31.2%
2019 → 2023
Net result
€-94k▼ 30.8%
2024 · €-72k
2019: €-3k
2020: €17k
2021: €-60k
2022: €-4k
2023: €43k
2024: €-72k
2019 → 2025
Working capital
€-60k
2024 · €56k
2019: €9k
2020: €26k
2021: €-34k
2022: €-38k
2023: €-19k
2024: €56k
2019 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Turnover€8k-€12k▲ 53.9%€73k▲ 523%
Equity€-34k-€-38k▼ 11.9%€5k€84k▲ 1,449%€-10k
Operating result€-56k-€-4k▲ 93.4%€43k€-70k€-89k▼ 26.6%
Net result€-60k-€-4k▲ 93.3%€43k€-72k€-94k▼ 30.8%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €89k in 2025 against €70k in 2024; the loss grows and 2025 is the lowest year so far.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €184k
Fixed assets
€113k▲ 301%
Current assets
€71k▼ 13.0%
Key figures and ratios
EBITDA
€-65k▲
2024 · €-66k
Cash flow
€-69k▼
2024 · €-67k
Solvency
-5.3%▼
2024 · 76.4%
Current ratio
0.54▼
2024 · 3.15
Quick ratio
0.54▼
2024 · 3.15
Debt / equity
-19.98▼
2024 · 0.31
ROE
965.4%▲
2024 · -85.3%
ROA
-50.9%▲
2024 · -65.1%
Interest coverage
-14.50▲
2024 · -51.01
Debt
€194k▲
2024 · €26k
Debt ≤ 1 year
€131k▲
2024 · €26k
Debt > 1 year
€37k
Income taxes
€168
Staff costs
€215k▲
2024 · €54k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€110k€184k▲
Fixed assets21/28€28k€113k▲
Intangible fixed assets21€17k€13k▼
Tangible fixed assets22/27-€89k
Plant, machinery and equipment23-€89k
Financial fixed assets28€11k€11k=
Current assets29/58€82k€71k▼
Amounts receivable within one year40/41€25k€26k▲
Trade receivables40€25k€26k▲
Other amounts receivable41€166€57▼
Cash at bank and in hand54/58€56k€45k▼
Equity and liabilities
Total equity and liabilities10/49€110k€184k▲
Equity10/15€84k€-10k▼
Contributions10/11€164k€164k=
Outside capital11€164k€164k=
Share premium1100/10€164k€164k=
Profit (loss) carried forward14€-80k€-174k▼
Amounts payable17/49€26k€194k▲
Amounts payable after more than one year17-€37k
Financial debts170/4-€37k
Amounts payable within one year42/48€26k€131k▲
Current portion of amounts payable after more than one year42-€31k
Trade debts44€7k€17k▲
Suppliers440/4€7k€17k▲
Taxes, remuneration and social security45€19k€24k▲
Taxes450/3€13k€6k▼
Remuneration and social security454/9€6k€18k▲
Other amounts payable47/48-€60k
Accrued charges and deferred income492/3-€25k
Income statement
Code20242025
Remuneration, social security and pensions62€54k€215k▲
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4k€24k▲
Non-recurring operating charges66A-€-3k
Gross operating margin9900€-12k€147k▲
Operating profit (loss)9901€-70k€-89k▼
Financial income75/76B-€0
Recurring financial income75-€0
Financial charges65/66B€1k€4k▲
Recurring financial charges65€1k€4k▲
Profit (loss) for the period before taxes9903€-72k€-93k▼
Income taxes67/77-€168
Profit (loss) for the period9904€-72k€-94k▼
Profit (loss) for the period to be appropriated9905€-72k€-94k▼
Appropriation of the result
Profit (loss) to be appropriated9906€-80k€-174k▼
Profit (loss) brought forward from the previous period14P€-9k€-80k▼
The notes to these accounts (9 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 31 days late
2025
31-12
Financial
Weakest financial yearnet €-94k
Net result drops to €-94k, the lowest in the series.
14-08
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema · 14 days late
2024
31-12
Financial
Liquidity triplescurrent ratio 3.15
Current ratio from 0.91 to 3.15; short-term debt falls from €217k to €26k.
22-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 22 days late
2023
31-12
Financial
Back to profitnet €43k
Net result €43k after 2 loss-making years.
29-08
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 29 days late
2022
30-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 30 days late
2021
30-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 30 days late
2020
31-12
Financial
Back to profitnet €17k
Net result €17k after one loss-making year.
10-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 41 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Eghezée · 2 establishment units since 2019
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue Louis Allaert,Noville 95310 EghezéeGround area
3.1 ha
Building footprint
721 m²
Volume, LiDAR
1,685 m³
2 parcels, Wallonia · tallest building 5.6 m, ±1 floor. Linked by address, not a title deed.
2 establishment units
SUPERBIOTICS SPRL
since 20192.303.058.924
SUPERBIOTICS SRL
since 20242.359.929.628
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 92065B0056/00X004 | Wallonia | 2.1 ha | 1 · 418 m² | 5.6 m · 1 fl. |
| 92335B0431/00T000 | Wallonia | 9,452 m² | 1 · 302 m² | - |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
B&W
BE 0650.763.201
Brugge · Eq €89k
DE KOEK
BE 0657.943.674
Brakel · Eq €92k
A&H
BE 0787.538.743
Sint-Pieters-Leeuw · Eq €92k
JELU
BE 0775.813.126
Kasterlee · Eq €76k
STERQ
BE 0755.861.612
Kortrijk · Eq €74k
Of 390 companies in sector 10890 we hold annual accounts for 221. 112 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded22-01-2019
Fiscal year end31-12
Trade name FR
Vésale Superbiotics
Activities, NACEBEL
10890Manufacture of food products
21100Manufacture of basic pharmaceutical products and pharmaceutical preparations
21209Manufacture of basic pharmaceutical products and pharmaceutical preparations
46150Agents in the wholesale of furniture, household goods and hardware
46460Wholesale of pharmaceutical and medical goods
Sources
Crossroads Bank for EnterprisesNational Bank · 7 filingsAddress and cadastre registers
Data from official sources, last processed on 11-09-2026. Scores and ratios are computed by Checked and are not a credit decision.